Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
- PMID: 31610546
- DOI: 10.7326/M19-2815
Direct Oral Anticoagulants in Antiphospholipid Syndrome: Too Early or Too Late?
Comment on
-
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial.Ann Intern Med. 2019 Nov 19;171(10):685-694. doi: 10.7326/M19-0291. Epub 2019 Oct 15. Ann Intern Med. 2019. PMID: 31610549 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources